logo

Propanc Biopharma Plans to Purchase $100 Million Worth of Ethereum in the Next 12 Months

By: theblockbeats.news|2025/09/02 13:52:27

BlockBeats News, September 2nd, US-listed biopharmaceutical company Propanc Biopharma (PPCB) announced plans to buy $100 million worth of Ethereum in the next 12 months. Propanc Biopharma stated that this move will enhance its overall corporate strategy in various areas such as cryptocurrency investment, drug development, and asset acquisition.

U.S. publicly traded company Empery Digital has announced an additional purchase of 16.51 BTC, increasing its total holdings to 4,081.39 BTC.
Data: Avalon Labs has collected a total of $5.48 million in fees since June.

You may also like

Share
copy

Gainers

Latest Crypto News

10:15

BiyaPay Analyst: HashKey's Listing Imminent, Hong Kong Stock Market Welcomes First Cryptocurrency Compliance Giant

09:45

A certain whale has accumulated 2.33 million LINK over the past six months, currently facing an unrealized loss of $10.5 million

09:45

CoinShares: Digital Asset Investment Products Saw $1.07 Billion in Net Inflows Last Week

09:45

Abraxas Capital has allocated half of its funds to purchase HYPE spot, with a position reaching $56 million.

09:15

BNP Paribas: Fed to Continue Cutting Interest Rates Next Year, Room for Further Decline in US Bond Yields

Read more
Community
icon
icon
icon
icon
icon
icon
icon

Customer Support@weikecs

Business Cooperation@weikecs

Quant Trading & MMbd@weex.com

VIP Servicessupport@weex.com